JP2004505017A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004505017A5 JP2004505017A5 JP2001587559A JP2001587559A JP2004505017A5 JP 2004505017 A5 JP2004505017 A5 JP 2004505017A5 JP 2001587559 A JP2001587559 A JP 2001587559A JP 2001587559 A JP2001587559 A JP 2001587559A JP 2004505017 A5 JP2004505017 A5 JP 2004505017A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- combination kit
- malarial agent
- amino
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003430 antimalarial agent Substances 0.000 description 8
- AEUAEICGCMSYCQ-UHFFFAOYSA-N 4-n-(7-chloroquinolin-1-ium-4-yl)-1-n,1-n-diethylpentane-1,4-diamine;dihydrogen phosphate Chemical compound OP(O)(O)=O.ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 AEUAEICGCMSYCQ-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229960002328 chloroquine phosphate Drugs 0.000 description 3
- 240000009188 Phyllostachys vivax Species 0.000 description 2
- 206010035503 Plasmodium vivax infection Diseases 0.000 description 2
- 201000009976 Plasmodium vivax malaria Diseases 0.000 description 2
- 208000005469 Vivax Malaria Diseases 0.000 description 2
- 230000000078 anti-malarial effect Effects 0.000 description 2
- 229940033495 antimalarials Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- ADCOUXIGWFEYJP-UHFFFAOYSA-N 3-[1-[4-[(6-methoxyquinolin-8-yl)amino]pentylamino]ethylidene]oxolan-2-one Chemical compound C=12N=CC=CC2=CC(OC)=CC=1NC(C)CCCNC(C)=C1CCOC1=O ADCOUXIGWFEYJP-UHFFFAOYSA-N 0.000 description 1
- -1 6-methoxy-8-quinolinyl Chemical group 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN501MU2000 | 2000-05-31 | ||
| PCT/IN2000/000081 WO2001091535A2 (en) | 2000-05-31 | 2000-08-30 | A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004505017A JP2004505017A (ja) | 2004-02-19 |
| JP2004505017A5 true JP2004505017A5 (https=) | 2007-10-04 |
Family
ID=11097250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001587559A Pending JP2004505017A (ja) | 2000-05-31 | 2000-08-30 | クロロキンおよび３−（１−（（（４−（（６−メトキシ−８−キノリニル）アミノ）ペンチル）アミノ）−エチリデン）−ジヒドロ−２（３ｈ）フラノンを含有するマラリア治療に使用される組み合わせキット |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7404962B1 (https=) |
| EP (1) | EP1292306B1 (https=) |
| JP (1) | JP2004505017A (https=) |
| KR (1) | KR20030025926A (https=) |
| AP (1) | AP1435A (https=) |
| AR (1) | AR028458A1 (https=) |
| AT (1) | ATE314848T1 (https=) |
| AU (2) | AU2879001A (https=) |
| BR (1) | BR0005247A (https=) |
| CA (1) | CA2413775C (https=) |
| CR (1) | CR6835A (https=) |
| CZ (1) | CZ296875B6 (https=) |
| DE (2) | DE60025403T2 (https=) |
| DK (1) | DK1292306T3 (https=) |
| EC (1) | ECSP003694A (https=) |
| ES (1) | ES2200729T3 (https=) |
| GT (1) | GT200000187A (https=) |
| HK (1) | HK1052467B (https=) |
| HN (1) | HN2001000118A (https=) |
| HU (1) | HUP0301925A3 (https=) |
| MX (1) | MXPA02011883A (https=) |
| NO (1) | NO324774B1 (https=) |
| OA (1) | OA12276A (https=) |
| PE (1) | PE20011319A1 (https=) |
| PL (1) | PL200748B1 (https=) |
| SV (1) | SV2002000201A (https=) |
| WO (1) | WO2001091535A2 (https=) |
| ZA (1) | ZA200209726B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2008135762A (ru) * | 2006-02-16 | 2010-03-27 | Де МакЛин Хоспитал Корпорейшн (US) | Способы и композиции для лечения болезни паркинсона |
| US8658648B2 (en) | 2008-12-05 | 2014-02-25 | Designmedix, Inc. | Modified chloroquines with single ring moiety or fused ring moiety |
| WO2010144102A1 (en) * | 2009-06-09 | 2010-12-16 | The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command | Pentafluorosulfanyl analogs of mefloquine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431807A (en) * | 1980-06-12 | 1984-02-14 | The United States Of America As Represented By The Secretary Of The Army | 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines |
| US5219865A (en) * | 1987-05-08 | 1993-06-15 | Hoechst Aktiengesellschaft | Pharmaceutical combination for the prophylaxis and therapy of malaria |
| US5373005A (en) * | 1988-04-20 | 1994-12-13 | Merrell Dow Pharmaceuticals Inc. | Despiramine in the treatment of drug-resistant malarial infections |
| US5270037A (en) * | 1990-07-12 | 1993-12-14 | Boehringer Ingelheim Gmbh | Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections |
| WO1993015727A1 (en) * | 1992-02-07 | 1993-08-19 | Ciba-Geigy Ag | Antimalarial synergistic compositions containing benflumetol |
-
2000
- 2000-08-30 US US10/296,215 patent/US7404962B1/en not_active Expired - Fee Related
- 2000-08-30 AU AU2879001A patent/AU2879001A/xx active Pending
- 2000-08-30 DE DE60025403T patent/DE60025403T2/de not_active Expired - Lifetime
- 2000-08-30 EP EP00993875A patent/EP1292306B1/en not_active Expired - Lifetime
- 2000-08-30 AU AU2001228790A patent/AU2001228790B2/en not_active Ceased
- 2000-08-30 PL PL372718A patent/PL200748B1/pl not_active IP Right Cessation
- 2000-08-30 AT AT00993875T patent/ATE314848T1/de active
- 2000-08-30 JP JP2001587559A patent/JP2004505017A/ja active Pending
- 2000-08-30 HK HK03104811.6A patent/HK1052467B/en not_active IP Right Cessation
- 2000-08-30 CZ CZ20024071A patent/CZ296875B6/cs not_active IP Right Cessation
- 2000-08-30 MX MXPA02011883A patent/MXPA02011883A/es active IP Right Grant
- 2000-08-30 DE DE0001292306T patent/DE00993875T1/de active Pending
- 2000-08-30 KR KR1020027016169A patent/KR20030025926A/ko not_active Ceased
- 2000-08-30 CA CA002413775A patent/CA2413775C/en not_active Expired - Fee Related
- 2000-08-30 HU HU0301925A patent/HUP0301925A3/hu unknown
- 2000-08-30 AP APAP/P/2002/002672A patent/AP1435A/en active
- 2000-08-30 OA OA1200200359A patent/OA12276A/en unknown
- 2000-08-30 ES ES00993875T patent/ES2200729T3/es not_active Expired - Lifetime
- 2000-08-30 DK DK00993875T patent/DK1292306T3/da active
- 2000-08-30 WO PCT/IN2000/000081 patent/WO2001091535A2/en not_active Ceased
- 2000-10-05 EC EC2000003694A patent/ECSP003694A/es unknown
- 2000-10-13 SV SV2000000201A patent/SV2002000201A/es unknown
- 2000-10-25 GT GT200000187A patent/GT200000187A/es unknown
- 2000-11-06 BR BR0005247-7A patent/BR0005247A/pt not_active Application Discontinuation
-
2001
- 2001-05-14 AR ARP010102288A patent/AR028458A1/es unknown
- 2001-05-23 PE PE2001000469A patent/PE20011319A1/es not_active Application Discontinuation
- 2001-05-30 HN HN2001000118A patent/HN2001000118A/es unknown
-
2002
- 2002-11-28 CR CR6835A patent/CR6835A/es not_active Application Discontinuation
- 2002-11-29 NO NO20025765A patent/NO324774B1/no not_active IP Right Cessation
- 2002-11-29 ZA ZA200209726A patent/ZA200209726B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR028504A2 (es) | Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial | |
| BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
| DE69225421D1 (de) | Sumatriptan enthaltende Arzneimittel | |
| JP3874793B2 (ja) | イブプロフェンおよびコデイン含有の改良された医薬処方 | |
| ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
| WO2004066910A3 (en) | Controlled release modifying complex and pharmaceutical compositions thereof | |
| EE04800B1 (et) | Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks | |
| NO20011721D0 (no) | N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor | |
| IL139227A0 (en) | N-substituted aminotetralins as ligands for the neuropeptide yy5 receptor useful in the treatment of obesity and other disorders | |
| JO2555B1 (en) | Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent | |
| CA2065652A1 (en) | Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts | |
| TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
| AP2003002763A0 (en) | Controlled release formulations for oral administration | |
| ATE252377T1 (de) | Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff | |
| JP2009517411A5 (https=) | ||
| WO1999033450A3 (en) | Pharmaceutical composition containing sibutramine and orlistat | |
| CA2489140A1 (en) | Dosage form containing pantoprazole as active ingredient | |
| RU99119233A (ru) | Фармацевтические композиции, содержащие ибупрофен и домперидон для лечения мигрени | |
| JP2004505017A5 (https=) | ||
| WO2000066550A8 (en) | New compounds | |
| WO2000048582A3 (de) | Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der drogenabhängigkeit | |
| JP2003523385A5 (https=) | ||
| AU2907800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism | |
| UA66925C2 (uk) | Поліморфні форми кристалічного цитрату азабіцикло[2.2.2]-октан-3-аміну, спосіб їх одержання, фармацевтична композиція та спосіб лікування блювання | |
| JP2005525391A5 (https=) |